| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 2.43% | 297.56% | 73.57% | 77/157 | 1.37% | 泽璟制药 | 44.02% | 行业排名> |
| 2026-03-31 | 1.4% | 418.52% | -81.98% | 74/157 | 0.06% | 泽璟制药 | 45.29% | 行业排名> |
| 2025-12-31 | 7.77% | 222.36% | 909.38% | 33/157 | -4.46% | 兴齐眼药 | 38.62% | 行业排名> |
| 2025-09-30 | -0.96% | 75.7% | 21.95% | 111/157 | 1.31% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | -1.23% | 65.74% | -555.56% | 114/157 | 0.3% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 0.27% | 113.43% | 104.25% | 102/157 | -0.34% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | -6.35% | 25.21% | -60.76% | 115/157 | -9.62% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | -3.95% | 44.44% | -10.03% | 125/157 | 4.28% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | -3.59% | 38.53% | -78.61% | 128/157 | 2.69% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | -2.01% | -1156.25% | 76.33% | 129/157 | 2.35% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | -8.49% | 47.72% | -19.41% | 124/157 | -1% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | -7.11% | 54.94% | -21.75% | 127/157 | 2.36% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | -5.84% | 32.41% | -3550% | 126/157 | 1.48% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | -0.16% | 95.66% | 99.01% | 117/157 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | -16.24% | -1476.7% | -2.92% | 130/157 | 0.79% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | -15.78% | 2% | -82.64% | 133/157 | 2.86% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | -8.64% | 2% | -738.84% | 137/157 | 2.21% | 小方制药 | 34.81% | 行业排名> |
| 2021-12-31 | -1.03% | 93.72% | 72.09% | 114/157 | 0.84% | 退市金泰 | 10.74% | 行业排名> |
| 2021-03-31 | -3.69% | 2% | 77.49% | 118/157 | 2.49% | ST人福 | 6.82% | 行业排名> |
| 2020-12-31 | -16.39% | -237.04% | -237.04% | 124/157 | 3.8% | 小方制药 | 71.99% | 行业排名> |
| 2019-12-31 | 11.96% | -57.1% | -57.1% | 41/157 | 2.57% | 汇宇制药 | 39.25% | 行业排名> |
| 2018-12-31 | 27.88% | 2% | 2% | 4/157 | 7.16% | 汇宇制药 | 28.14% | 行业排名> |

微信公众号
证券之星APP


